Abstract #0702

First Application of Automated Hippocampal Subfield Segmentation using 7T MRI in Patients with Major Depressive Disorder

Judy Alper^1,2, Rui Feng³, Hadrien Dyvorne¹, Long Xie⁴, Marin Kautz⁵, Hung-Mo Lin⁶, Bradley N Delman⁷, Patrick Hof⁸, James Murrough^5,8, and Priti Balchandani¹

¹Radiology, Icahn School of Medicine At Mount Sinai, New York, NY, United States, ²Biomedical Engineering, City College of New York, New York, NY, United States, ³Neurosurgery, Icahn School of Medicine At Mount Sinai, New York, NY, United States, ⁴Biomedical Engineering, University of Pennsylvania, Philadelphia, PA, United States, ⁵Psychiatry, Icahn School of Medicine At Mount Sinai, New York, NY, United States, ⁶Population Health Science and Policy Department, Icahn School of Medicine At Mount Sinai, New York, NY, United States, ⁷Radiology, Mount Sinai Medical Center, New York, NY, United States, ⁸Neuroscience, Icahn School of Medicine At Mount Sinai, New York, NY, United States

Major depressive disorder (MDD) is a debilitating illness, which is widely prevalent. There is a need to elucidate MDD pathophysiology to better target treatment. Studies have shown association between hippocampal subfield volumes and MDD, making the subfields potential biomarkers. We use high-resolution 7T-MRI to perform effective subfield delineations and evaluate subfield volume differences between sixteen patients and sixteen controls. Using automatic segmentation of hippocampal subfields software revealed a trend towards reduced right-CA1 and right-DG subfield volumes in patients compared to controls. Identifying hippocampal subfield volumes as imaging biomarkers for MDD may help design more targeted treatments for the disease.

This abstract and the presentation materials are available to members only; a login is required.

Join Here